Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
The mycosis fungoides cutaneous microenvironment shapes dysfunctional cell trafficking, antitumor immunity, matrix interactions, and angiogenesis
Alyxzandria M. Gaydosik, Connor J. Stonesifer, Tracy Tabib, Robert Lafyatis, Larisa J. Geskin, Patrizia Fuschiotti
Alyxzandria M. Gaydosik, Connor J. Stonesifer, Tracy Tabib, Robert Lafyatis, Larisa J. Geskin, Patrizia Fuschiotti
View: Text | PDF
Research Article Dermatology Oncology

The mycosis fungoides cutaneous microenvironment shapes dysfunctional cell trafficking, antitumor immunity, matrix interactions, and angiogenesis

  • Text
  • PDF
Abstract

Malignant T lymphocyte proliferation in mycosis fungoides (MF) is largely restricted to the skin, implying that malignant cells are dependent on their specific cutaneous tumor microenvironment (TME), including interactions with non-malignant immune and stromal cells, cytokines, and other immunomodulatory factors. To explore these interactions, we performed a comprehensive transcriptome analysis of the TME in advanced-stage MF skin tumors by single-cell RNA sequencing. Our analysis identified cell-type compositions, cellular functions, and cell-to-cell interactions in the MF TME that were distinct from those from healthy skin and benign dermatoses. While patterns of gene expression were common among patient samples, high transcriptional diversity was also observed in immune and stromal cells, with dynamic interactions and crosstalk between these cells and malignant T lymphocytes. This heterogeneity mapped to processes such as cell trafficking, matrix interactions, angiogenesis, immune functions, and metabolism that affect cancer cell growth, migration, and invasion, as well as antitumor immunity. By comprehensively characterizing the transcriptomes of immune and stromal cells within the cutaneous microenvironment of individual MF tumors, we have identified patterns of dysfunction common to all tumors that represent a resource for identifying candidates with therapeutic potential as well as patient-specific heterogeneity that has important implications for personalized disease management.

Authors

Alyxzandria M. Gaydosik, Connor J. Stonesifer, Tracy Tabib, Robert Lafyatis, Larisa J. Geskin, Patrizia Fuschiotti

×

Figure 6

Single-cell EC transcriptome in the MF TME.

Options: View larger image (or click on image) Download as PowerPoint
Single-cell EC transcriptome in the MF TME.
(A) Transcriptomes of 3,319 ...
(A) Transcriptomes of 3,319 VWF+ cells (2,503 from HC [n = 9] and 816 from MF [n = 7] samples) revealing grouping in each MF sample compared with all HC skin samples. Cells from each subject are indicated by different colors. (B) t-SNE plots show expression of indicated EC marker genes. (C) Dot plots showing the proportion of cells and the scaled average gene expression of cutaneous EC markers from individual MF and HC samples as indicated. (D and E) Average expression levels of marker genes for pro-angiogenic (D) and immunomodulatory (E) factors by ECs from individual MF samples. (F) Heatmap shows average expression of genes (n = 265) commonly expressed by all MF samples. Each tumor was compared with the controls for significant differential expression (P value < 0.05, log fold change 0.1, minimum percentage 10%) to find common genes between tumors. Examples of commonly expressed genes are shown. (G) Individual tumors compared with control significant differential expression gene lists (P value < 0.05, log fold change 0.1, minimum percentage 10%) were analyzed in IPA and then compared with each other for common pathways. Heatmap shows z scores of pathways for up- or downregulation of pathways. (H) Multicolor immunofluorescence microscopy staining for CD31 and SOX18 in advanced MF (n = 7) and HC (n = 4) skin samples. Representative examples are shown (×1,000). DAPI stains nuclei.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts